Kenshi Fujii

Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction.

Hiroshi Ito, T Tomooka, Noriko Sakai et al. · Circulation · 1992 · 1.1K citations · Full text

Clinical Implications of the ‘No Reflow’ Phenomenon

Hiroshi Ito, Atsushi Maruyama, Katsuomi Iwakura et al. · Circulation · 1996 · 1K citations

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 855 citations · Full text

Thrombosis, Cardiovascular Disease, Stroke +13

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 749 citations · Full text

Thrombosis, Cardiovascular Disease, Atherosclerosis +12

Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials

Masafumi Kitakaze, Masanori Asakura, Jiyoong Kim et al. · The Lancet · 2007 · 469 citations

Thrombosis, Cardiovascular Disease, Cardiovascular Pharmacology +4